Literature DB >> 26196061

A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.

Bisheng Jiang1, Dehua Pei1.   

Abstract

Pin1 regulates the levels and functions of phosphoproteins by catalyzing phosphorylation-dependent cis/trans isomerization of peptidyl-prolyl bonds. Previous Pin1 inhibitors contained phosphoamino acids, which are metabolically unstable and have poor membrane permeability. In this work, we report a cell-permeable and metabolically stable nonphosphorylated bicyclic peptide as a potent and selective Pin1 inhibitor, which inhibited the intracellular Pin1 activity in cultured mammalian cells but had little effect on other isomerases such as Pin4, FKBP12, or cyclophilin A.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26196061      PMCID: PMC4594195          DOI: 10.1021/acs.jmedchem.5b00411

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  38 in total

1.  Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.

Authors:  Kelly E Duncan; Brian R Dempsey; Lauren E Killip; Jarrett Adams; Melanie L Bailey; Gilles A Lajoie; David W Litchfield; Christopher J Brandl; Gary S Shaw; Brian H Shilton
Journal:  J Med Chem       Date:  2011-05-05       Impact factor: 7.446

2.  Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocket.

Authors:  Chuangxing Guo; Xinjun Hou; Liming Dong; Joseph Marakovits; Samantha Greasley; Eleanor Dagostino; RoseAnn Ferre; M Catherine Johnson; Paul S Humphries; Haitao Li; Genevieve D Paderes; Joseph Piraino; Eugenia Kraynov; Brion W Murray
Journal:  Bioorg Med Chem Lett       Date:  2014-07-22       Impact factor: 2.823

3.  Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.

Authors:  Tao Liu; Yu Liu; Hung-Ying Kao; Dehua Pei
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

4.  Pin1 inhibitors: Pitfalls, progress and cellular pharmacology.

Authors:  Jonathan D Moore; Andrew Potter
Journal:  Bioorg Med Chem Lett       Date:  2013-06-06       Impact factor: 2.823

5.  A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.

Authors:  Tadashi Mori; Masafumi Hidaka; Yi-Chin Lin; Ibuki Yoshizawa; Takayoshi Okabe; Shinichiro Egashira; Hirotatsu Kojima; Tetsuo Nagano; Mamoru Koketsu; Mari Takamiya; Takafumi Uchida
Journal:  Biochem Biophys Res Commun       Date:  2011-02-17       Impact factor: 3.575

6.  Requirement of the prolyl isomerase Pin1 for the replication checkpoint.

Authors:  K E Winkler; K I Swenson; S Kornbluth; A R Means
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

7.  Screening bicyclic peptide libraries for protein-protein interaction inhibitors: discovery of a tumor necrosis factor-α antagonist.

Authors:  Wenlong Lian; Punit Upadhyaya; Curran A Rhodes; Yusen Liu; Dehua Pei
Journal:  J Am Chem Soc       Date:  2013-08-01       Impact factor: 15.419

8.  A human peptidyl-prolyl isomerase essential for regulation of mitosis.

Authors:  K P Lu; S D Hanes; T Hunter
Journal:  Nature       Date:  1996-04-11       Impact factor: 49.962

9.  Cyclohexyl ketone inhibitors of Pin1 dock in a trans-diaxial cyclohexane conformation.

Authors:  Guoyan G Xu; Carla Slebodnick; Felicia A Etzkorn
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

10.  Cell-permeable bicyclic peptide inhibitors against intracellular proteins.

Authors:  Wenlong Lian; Bisheng Jiang; Ziqing Qian; Dehua Pei
Journal:  J Am Chem Soc       Date:  2014-07-02       Impact factor: 15.419

View more
  10 in total

1.  Designing Cell-Permeable Macrocyclic Peptides.

Authors:  George Appiah Kubi; Patrick G Dougherty; Dehua Pei
Journal:  Methods Mol Biol       Date:  2019

Review 2.  Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.

Authors:  Bryan M Dunyak; Jason E Gestwicki
Journal:  J Med Chem       Date:  2016-07-25       Impact factor: 7.446

3.  Development of a Cell-Permeable Cyclic Peptidyl Inhibitor against the Keap1-Nrf2 Interaction.

Authors:  Heba Salim; Jian Song; Ashweta Sahni; Dehua Pei
Journal:  J Org Chem       Date:  2019-10-28       Impact factor: 4.354

Review 4.  Bicyclic Peptides as Next-Generation Therapeutics.

Authors:  Curran A Rhodes; Dehua Pei
Journal:  Chemistry       Date:  2017-07-27       Impact factor: 5.236

5.  Inhibition of peptidyl-prolyl isomerase (PIN1) and BRAF signaling to target melanoma.

Authors:  Christina Braun; Nadja Schneider; Dehua Pei; Anja Bosserhoff; Silke Kuphal
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

6.  Cell-Permeable Bicyclic Peptidyl Inhibitors against NEMO-IκB Kinase Interaction Directly from a Combinatorial Library.

Authors:  Curran A Rhodes; Patrick G Dougherty; Jahan K Cooper; Ziqing Qian; Steffen Lindert; Qi-En Wang; Dehua Pei
Journal:  J Am Chem Soc       Date:  2018-09-11       Impact factor: 15.419

7.  Understanding Cell Penetration of Cyclic Peptides.

Authors:  Patrick G Dougherty; Ashweta Sahni; Dehua Pei
Journal:  Chem Rev       Date:  2019-05-14       Impact factor: 60.622

8.  Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.

Authors:  Joshua Schwochert; Yongtong Lao; Cameron R Pye; Matthew R Naylor; Prashant V Desai; Isabel C Gonzalez Valcarcel; Jaclyn A Barrett; Geri Sawada; Maria-Jesus Blanco; R Scott Lokey
Journal:  ACS Med Chem Lett       Date:  2016-06-06       Impact factor: 4.345

9.  Cell-permeable bicyclic peptidyl inhibitors against T-cell protein tyrosine phosphatase from a combinatorial library.

Authors:  Hui Liao; Dehua Pei
Journal:  Org Biomol Chem       Date:  2017-11-22       Impact factor: 3.876

10.  Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides.

Authors:  Thi B Trinh; Punit Upadhyaya; Ziqing Qian; Dehua Pei
Journal:  ACS Comb Sci       Date:  2015-12-23       Impact factor: 3.784

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.